Introduction {#sec1-1}
============

Dengue viral infection (DVI) is one of the most important mosquito-borne diseases in the world. In India, the first proven epidemic of dengue fever (DF) occurred in Kolkata in 1963--1964.\[[@ref1]\] With rapidly changing epidemiology, the footprint of DVI has dramatically expanded over the past few decades. At present, all the four serotypes are seen, but the predominant serotype varies with time.\[[@ref2][@ref3]\] The clinical spectrum of DVI ranges from self-limiting illness to life-threatening dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS).

Several mechanisms have been proposed for DF-induced acute kidney injury (AKI), including direct action by the virus, hemodynamic instability, rhabdomyolysis, and acute glomerular injury. Previous studies have shown great disparity in the incidence of dengue induced AKI ranging from 0.83% to 13.3%.\[[@ref4][@ref5][@ref6]\] In most of the previously conducted studies, AKI incidence was reported in patients with DHF,\[[@ref7][@ref8][@ref9][@ref10]\] and only few studies have reported the incidence of AKI in DVI.\[[@ref4][@ref5][@ref7][@ref8]\] Given the epidemic potential and endemicity of DVI in India, the aim of this retrospective study was to evaluate the incidence, clinical characteristics, severity, predictors of AKI, and impact of AKI on the length of hospital stay and mortality in DVI.

Materials and Methods {#sec1-2}
=====================

This was a retrospective study done of dengue virus infected cases admitted from January 2016 to December 2017 in the Department of Medicine at King George\'s Medical University, Lucknow, Uttar Pradesh, India. Data were collected after receiving approval from Institutional Ethics Committee. Study subjects included inpatients \>14 years of age, admitted with primary diagnosis of DVI, and confirmed dengue IgM antibodies irrespective of severity of DVI. Patients with chronic kidney disease, those with no laboratory evidence of DVI, or single positive dengue IgG results were excluded from the study. Suspected DVI cases were diagnosed using at least one of the following criteria:

Positive reverse transcriptase--polymerase chain reaction resultPresence of dengue immunoglobulin M and G antibodies in acute phase serum by enzyme-linked immunosorbent assay. Primary dengue infection was distinguished from secondary infection using IgM/IgG ratio where dengue infection was defined as primary if ratio was \>1.2 and as secondary if \<1.2. NS1 antigen and IgM antibody were done using NIV Dengue IgM Capture ELISA Kit (Pune Maharashtra, India) and IgG by capture ELISA Kits, NovaTec (Dietzenbach, Frankfurt, Germany)At least 4-fold increase in dengue-specific hemagglutination inhibition titers in convalescent serum when compared with acute phase serum.

As per World Health Organization (WHO) criteria, patients with DF and hemorrhagic manifestations, low platelet count (≤100 × 10^3^/μL), and objective evidence of leaky capillaries (≥20% elevation in hematocrit, low serum albumin, and pleural or other effusions) were classified as having DHF (WHO classification, DHF grades I/II). Those with evidence of circulatory failure (pulse pressure ≤20 mmHg, hypotension, or shock) were classified as having DSS (WHO classification, DHF grades III/IV). Warning signs were defined as presence of at least one of the following: abdominal pain/tenderness, persistent vomiting, clinical fluid accumulation, mucosal bleed, lethargy/restlessness, liver enlargement \>2 cm, and concurrent increase in hematocrit with thrombocytopenia.\[[@ref11]\] AKI was defined as per Acute Kidney Injury Network (AKIN) classification.\[[@ref12]\] Renal outcome was defined according to Acute Dialysis Quality Initiative consensus guidelines. Complete renal recovery was defined as a return to baseline creatinine and a partial recovery as an improvement in RIFLE status of a patient free of dialysis.\[[@ref13]\]

Hospital stay was defined as \>1-day bed occupancy in hospital, mortality as death within 14 days of admission, hypokalemia as serum potassium \<3.5 mmol/L, and hyponatremia as serum sodium \<135 mmol/L. Urine output was measured by indwelling catheter in hemodynamically unstable patients/unconscious patients, and oliguria was defined as urine output \<400 mL/day after 24 h of appropriate hydration. Hypotension was defined as blood pressure \<110/70 mmHg, proteinuria as urinary protein ≥1+ (30 mg/dL) by dipstick test, and microscopic hematuria as \>5 RBCs/HPF. Urinary sediment was defined as the presence of glycosuria, hematuria, proteinuria, leucocytouria, urine pus cells, and/or urine epithelial cells; anemia as Hb \<12 g/dL; dengue viral infection as DF, DHF, or DSS; severe dengue as DHF or DSS; mild AKI as AKIN-I; severe AKI as AKIN-II or AKIN-III; and multiple-organ dysfunction as dysfunction of \>2 organs, including AKI. The patients were divided into two cohorts (those with and without AKI) to determine independent predictors of AKI. Similarly, two cohorts were also made to study the impact of AKI on the length of hospital stay. Data pertaining to age, gender, comorbidities, laboratory investigations, and mortality of each patient were obtained from medical records. An automated blood-cell analyzer (Abbott Cell Dyn Ruby Hematology Analyzer; Abbott, Abbott Park, IL, USA) was used for routine hematology testing, and an automated clinical biochemistry analyzer (Elitech Selectra PROM) (ELITechGroup, Puteaux, France) was used for measurement of blood urea nitrogen, creatinine, electrolytes, serum bilirubin, and albumin. Proteinuria was measured by dipstick test (Sidak Life Care Pvt. Ltd., Peera Garhi, Delhi, India).

Statistical analysis {#sec2-1}
--------------------

Categorical variables were presented as percentages and compared using χ^2^ test. Fisher\'s exact test was used when the expected count was less than five in any cell. Quantitative data were expressed as mean ± SD. One-way analysis of variance was used to compare the mean values among various groups in case of normally distributed data. Quantitative variables with non-normal distribution were compared by Mann--Whitney *U*-test between groups. Odds ratio (OR) and their 95% confidence intervals (CIs) for the predictors of AKI were estimated using multivariate logistic regression analysis models. Kaplan--Meier analysis was used for probability of survival among groups with DF and DHF/DSS with or without renal impairment with the period of follow-up taken from the day of hospitalization till the day of patient discharge. Mortality among patients was taken as the event of interest. The criterion of significance was set at *p* \< 0.05. All calculations were carried out using Stata IC 13.1 software (StataCorp LP, USA).

Results {#sec1-3}
=======

Among the 620 patients, 353 (56.93%) were male and 267 (43.06%) were female, with a mean age of 31.6 ± 12.8 and 29.6 ± 11.2 years, respectively. A total of 454 (73.22%) patients had classical DF, 141 (22.74%) patients had DHF, and 25 (4.03%) patients had DSS. The most common symptoms were fever followed by headache and pain in abdomen. We found significant differences in age (*p* = 0.007), gender (*p* \< 0.001), dengue classification (*p* \< 0.001), underlying diseases (*p* \< 0.001), rhabdomyolysis (*p* \< 0.001), and urinary sedimentations (*p* \< 0.001) between AKI and non-AKI groups. Among all AKI cases, hypokalemia was observed in 28.22% of patients, while oliguria was present in 46.77% of patients. Comorbid diseases, for example, diabetes mellitus (*p* \< 0.001), hypertension (*p* \< 0.001), and ischemic heart disease (*p* \< 0.001) were more commonly found in patients with AKI. The mean duration of illness in AKI and non-AKI groups was 5.94 ± 0.82 and 2.24 ± 0.76 days, respectively. Patients with DHF/DSS were more prone to develop AKI when compared with the DF group (73.33% versus 26.67%) \[[Table 1](#T1){ref-type="table"}\].

###### 

Comparison of patients between non-AKI and AKI group with DVI

  Parameters                          Overall patients (*n*=620)   Non-AKI group (*n*=530)   AKI group (*n*=90)   *p*
  ----------------------------------- ---------------------------- ------------------------- -------------------- ---------
  Age group                                                                                                       
   14-60 years (%)                    580 (93.54)                  495 (93.4)                85 (94.44)           0.007
   \>60 years                         40 (6.451)                   35 (6.6)                  5 (5.56)             
  Gender                                                                                                          
   Male                               353 (56.93)                  275 (51.9)                75 (83.34)           \<0.001
   Female                             267 (43.06)                  255 (48.1)                15 (16.66)           
  Residence                                                                                                       
   Urban                              380 (61.29)                  320 (60.37)               65 (72.22)           \<0.005
   Rural                              240 (38.70)                  210 (39.63)               25 (27.78)           
  Diagnosis                                                                                                       
   DF (%)                             454 (73.22)                  430 (81.3)                24 (26.67)           \<0.001
   DHF (%)                            141 (22.74)                  95 (17.92%)               46 (51.1)            \<0.001
   DSS (%)                            25 (4.03)                    5 (0.94)                  20 (22.23)           \<0.05
   DHF/DSS (%)                        166 (26.77)                  100 (18.86%)              66 (73.33)           \<0.001
  Premorbid disease                                                                                               
   Diabetes (%)                       37 (5.96)                    20 (3.77)                 17 (18.88)           \<0.001
   Hypertension (%)                   35 (5.64)                    20 (3.77)                 15 (16.66)           \<0.001
   IHD (%)                            25 (4.03)                    18 (3.39)                 7 (7.77)             \<0.001
   CHF (%)                            5 (0.80)                     3 (0.56)                  2 (2.22)             0.88
   Hospitalization \>3 days (%)       320 (51.61)                  270 (50.94)               50 (55.55)           0.001
   Mean duration of hospitalization   3.94±0.62                    2.24±0.76                 5.94±0.82            \<0.001
  Urine examination                                                                                               
   Proteinuria (%)                    90 (14.51)                   65 (12.26)                25 (27.7)            \<0.001
   Hematurea (%)                      15 (2.41)                    7 (1.32)                  8 (8.8)              0.002

AKI: Acute kidney injury, DF: Dengue fever, DHF: Dengue hemorrhagic fever, DSS: Dengue shock syndrome, IHD: Ischemic heart disease, CHF: Congestive heart failure, MODS: Multiorgan dysfunction syndrome (referred as dysfunction of ≥2 organ system); PT: Prothrombin time, aPTT: Activated prothrombin time

Ninety (16.3%) patients developed AKI in this study; 31 (34.4%) patients had AKIN stage 1, 33 (36.6%) AKIN stage 2 and 26 (28.8%) AKIN stage 3 \[[Table 2](#T2){ref-type="table"}\]. During hospital stay, 11 (12.2%) patients progressed to a different stage (six patients from stage I to II and five patients from stage II to III). Dialysis was required in 20 (22.23%) subjects with AKI, out of which 14 patients died after two to three dialysis sessions. Among patients who died, only three patients died of secondary infection. The remaining 11 patients died of shock as a result of either intractable bleeding or severe DHF/DSS-induced multiple-organ failure (MOF). No one died as a result of complications of AKI \[[Table 3](#T3){ref-type="table"}\]. Among patients with AKI who were alive at the time of discharge from hospital, 75 patients (83.33%) had complete recovery of kidney function and only 15 (16.66%) continued to have some degree of renal dysfunction.

###### 

Frequency and severity of AKI in dengue viral infection

  Stage of AKI   AKI at presentation   AKI during in hospital stay   Total        No. of progressors                                     
  -------------- --------------------- ----------------------------- ------------ -------------------- ------------ ------------ --- --- ---
  Grade I        7 (22.5%)             10 (32.2%)                    9 (29.0%)    26 (83.8%)           5 (16.1%)    31 (34.4%)   X   X   X
  Grade II       12 (36.3%)            7 (21.2%)                     10 (30.3%)   29 (87.8%)           4 (12.1%)    33 (36.6%)   6   X   X
  Grade III      0                     10 (38.4%)                    14 (53.8%)   24 (92.3%)           2 (7.6%)     26 (28.8%)   X   5   X
  *n*=90                                                                          79 (87.7%)           11 (12.2%)                6   5   X

AKI: Acute kidney injury, DF: Dengue fever, DHF: Dengue hemorrhagic fever, DSS: Dengue shock syndrome

###### 

Patients' outcome at discharge

  Outcome                              AKI group (*n*=90)
  ------------------------------------ --------------------
  Renal function at discharge          
  Complete recovery                    75 (83.33%)
  Partial recovery                     15 (16.66%)
  Need for renal replacement therapy   20 (22.23%)
  Morality                             14 (15.55%)

AKI: Acute kidney injury

Kaplan--Meier survival analysis was based on total survival days from the day of admission to discharge, among patients with DF or DHF/DSS in the renal impairment group and non-renal impairment group. Patients with DHF/DSS in the renal impairment group had significantly higher mortality when compared with other groups by log-rank test (*p* \< 0.001) \[[Figure 1](#F1){ref-type="fig"}\].

![Kaplan--Meier survival analysis based on total hospitalization days from the day of admission to discharge, among patients with dengue fever (DF) or dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) in the renal impairment group and in non-renal impairment group. Patients with DHF/DSS in the renal impairment group had significantly higher mortality when compared with other groups by log-rank test (*P* \< 0.001)](IJN-29-15-g001){#F1}

Using multivariate logistic regression models, we found that the factors independently associated with AKI development were male gender (OR: 2.9, CI: 1.28--5.89), DHF (OR: 7.9, CI: 3.69--18.60), rhabdomyolysis (OR: 8.2, CI: 3.14--21.52), multiple-organ dysfunction (OR: 18.2, CI: 9.24--36.24), hypertension (OR: 0.7, CI: 0.25--2.76), diabetes mellitus (OR: 4.8, CI: 1.15--18.97), delayed hospitalization (OR: 2.2, CI: 1.07--4.23), and use of nephrotoxic drugs (OR: 2.86, CI: 1.36--6.22) \[[Table 4](#T4){ref-type="table"}\]. In all, 320 patients (51.61%) had length of hospital stay of more than 3 days, whereas the remaining 300 (48.38%) had length of hospital stay of \<3 days. We found that AKI was an independent predictor for increased length of hospital stay (OR: 7.2, 95% CI: 4.8--10.7) \[[Table 5](#T5){ref-type="table"} and [Figure 1](#F1){ref-type="fig"}\].

###### 

Predictors of AKI

  Variable                   Univariate analysis   Multivariate analysis                                  
  -------------------------- --------------------- ----------------------- ------------- --------- ------ ------------
  Age                        0.007                 3.2                     1.35-6.98     0.945     1.2    0.28-4.16
  Male gender                \<0.001               7.9                     4.82-13.72    0.015     2.9    1.28-5.89
  DHF                        \<0.001               7.5                     4.39-12.67    \<0.001   7.9    3.69-18.60
  Rhabdomyolysis             \<0.001               18.5                    10.70-42.25   \<0.001   8.2    3.14-21.52
  MODS                       \<0.001               32.5                    19.62-56.78   \<0.001   18.2   9.24-36.24
  Hypertension               \<0.001               5.8                     2.82-11.54    0.564     0.7    0.25-2.76
  Diabetes                   \<0.001               10.8                    5.32-22.32    0.051     4.8    1.15-18.97
  Delayed hospitalization    0.007                 1.6                     1.17-2.92     0.032     2.2    1.07-4.23
  Use of nephrotoxic drugs   \<0.001               9.4                     5.82-15.20    0.005     2.86   1.36-6.22

AKI: Acute kidney injury, OR: Odds ratio, CI: Confidence interval, DHF: Dengue hemorrhagic fever, MODS: Multiorgan dysfunction

###### 

Impact of AKI on the length of hospital stay and mortality

  Length of hospital stay                                     
  ------------------------- ----------- --------------------- ------------------------
  \<3 days                  \>3 days    Univariate analysis   Multivariate analysis
  64 (71.1)                 26 (28.9)   *p*\<0.001            95% CI; 7.2 (4.8-10.7)
  Mortality                                                   
  AKI                       No AKI      Univariate analysis   Multivariate analysis
  14 (15.55)                0 (0)       *p*\<0.001            \-

AKI: Acute kidney injury, CI: Confidence interval

Discussion {#sec1-4}
==========

Tropical acute febrile illnesses are common causes of AKI in developing countries. DF along with other tropical infections such as malaria, scrub typhus, and leptospirosis have been reported to cause AKI.\[[@ref14]\] There are multiple proposed mechanisms for the etiopathogenesis of renal impairment in DVI. Dengue causes capillary leakage and loss of fluid from the intravascular compartment leading to shock,\[[@ref15][@ref16]\] which may lead to decreased kidney perfusion and acute tubular necrosis. Deposition of immune complexes in glomeruli,\[[@ref17]\] hemolytic uremic syndrome,\[[@ref14]\] MOF, rhabdomyolysis or myositis, and direct viral invasion are some pathological mechanisms causing AKI in DVI.\[[@ref18]\] The presence of viral antigens in tubular epithelial cells has been demonstrated.\[[@ref19]\]

This study compared all types of dengue infection with regard to the risk of developing AKI. Our analysis stratified patients on the basis of AKIN criteria. The incidence of AKI was 14.51% in our study cohort. Previous studies have reported incidence of AKI as 13.3%\[[@ref4]\] and 10.8%\[[@ref5]\] in dengue infection, irrespective of severity. This variation can be explained by differences in study design, the population studied, and definition of AKI used. Higher incidence of AKI in our study might be due to the selection of in patients as study population and delayed referral. Approximately 40% cases were referred from rural areas where medical resources are deficient. In the five studies comparing patients with dengue with and without AKI, AKIN and serum creatinine \>2 mg/dL were the two criteria used to stratify patients with dengue into AKI \[[Table 6](#T6){ref-type="table"}\]. Use of the latter definition might ignore AKIN-I cases that accounted for 34.45% of AKI cases in our study.

###### 

Summary of studies comparing patients with dengue with and without AKI

  Author's name                                Study population                    Demographics (*n*, age, gender)            Severity of dengue   AKI definition   Incidence of AKI   Longer hospitalization (AKI vs non-AKI)   Mortality (AKI vs. non AKI)
  -------------------------------------------- ----------------------------------- ------------------------------------------ -------------------- ---------------- ------------------ ----------------------------------------- -----------------------------
  Lee *et al*.\[[@ref7]\] (retrospective)      Patients of all age groups          304, 139 males, age range 19-88 years      DHF                  SCr \>2 mg/dL    3.3%               NR                                        60% vs. 0%
  Lee *et al*.\[[@ref9]\] (retrospective)      Patients of all age groups          307, 139 males, age range 37-74 years      DHF                  SCr \>2 mg/dL    3.9%               NR                                        NR
  Mehra *et al*.\[[@ref5]\] (retrospective)    Patients of all age groups          223, 130 males, mean age 26.2±18.2 years   DVI                  AKIN             10.8%              NR                                        Overall: 9%\*
  AKIN-I: 5.4%                                                                                                                                                                                                                   
  AKIN-II: 3.1%                                                                                                                                                                                                                  
  AKIN-III: 2.2%                                                                                                                                                                                                                 
  Khalil *et al*.\[[@ref5]\] (retrospective)   Patients of all age groups          532, 377 males, mean age 35.2±14.7 years   DVI                  AKIN             13.3%              59.2% vs. 22.6%                           11.3% vs. 0%
  AKIN-I: 64.8%                                                                                                                                                                                                                  
  AKIN-II: 18.3%                                                                                                                                                                                                                 
  AKIN-III: 16.9%                                                                                                                                                                                                                
  Mallhi *et al*.\[[@ref8]\] (retrospective)   Age group \>12 years                667, 378 male, 289 female                  DVI                  AKIN             14.2%              65.3% vs. 48.3%                           8.4% vs. 0%
  Our study (retrospective)                    Patients of age groups \>14 years   620, 353 males, 267 female                 DVI                  AKIN             16.36%             55.55% vs. 50.9%                          15.61% vs. 0%

*n*: Number of patients enrolled in study, DVI: Dengue viral infection including all severities (DF, DHF, DSS), AKI: Acute kidney injury, AKIN: Acute Kidney Injury Network classification, AKIN-I, II, III, three severity stages of AKIN network classification, DHF: Dengue hemorrhagic fever, DSS: Dengue shock syndrome, SCr: Serum creatinine (mg/dL), NR: Not reported

Previous study reports suggested that DHF and DSS are associated with an increased risk for development of AKI.\[[@ref7][@ref9]\] Our results have supported these findings. Among 90 patients with AKI, 66 (26.77%) had severe dengue (DHF and DSS), and logistic regression demonstrated that patients with severe dengue were more likely to develop AKI (OR: 7.9). Of 90 patients with AKI, rhabdomyolysis was present in 18 (20%) patients with OR of 8.2 and multiple-organ dysfunctions in 40 (44.45%) with OR of 18.2. Based on these findings, it can be hypothesized that AKI in our patients might be due to the presence of rhabdomyolysis, hemolysis, hypotension, multiple-organ dysfunction, or severe dengue (DHF and DSS).

Male gender was overrepresented in our study and had a higher risk of developing AKI. Increased mobility of male population (OR: 2.9) and better access to healthcare facilities could explain the higher incidence of dengue infection and AKI among males. The use of nephrotoxic drugs (45, 50%) was also significantly (*p* \< 0.001) higher in patients with AKI. Approximately half of the patients with AKI were using nephrotoxic drugs for their comorbidities. These agents impair the critical autoregulation of renal blood flow and result in ischemic AKI.\[[@ref20]\] Our findings suggested that patients using nephrotoxic drugs have 9.4 times more chances of having AKI when compared with non-users of these drugs. Therefore, optimal measures should be taken to avoid exposure to such drugs among patients with dengue.

Dengue infection is associated with significant morbidity and mortality and imposes an enormous economic burden on the healthcare system of the country.\[[@ref21][@ref22]\] The mean length of hospital stay in patients with dengue had been reported to be 3--4 days in various studies. Khan *et al*.\[[@ref23]\] from Saudi Arabia reported a length of stay of 4 days. Similarly, a study from Singapore reported the mean stay as 3 days.\[[@ref24]\] Parkash *et al*.\[[@ref25]\] reported a mean hospital stay of 4 days in patients with associated hepatitis. The mean length of stay in our study was 3--4 days, which is comparable with internationally reported data. Moreover, we found that AKI was associated with a longer hospital stay and hence is an independent predictor for length of hospitalization. We found that patients who were admitted on or after day 3 of illness had 2.2 times the risk of developing AKI. In such cases, early hospitalization may reduce the risk of AKI and deterioration of clinical condition. Besides these, early hospitalization among dengue patients may also reduce the risk of mortality and progression to severe dengue.\[[@ref26]\]

Various studies have reported a mortality rate of 2.6%--2.7% in the general population infected with DVI.\[[@ref25][@ref27]\] International data report a variable mortality rate ranging from 0% to 3.7%.\[[@ref28][@ref29][@ref30][@ref31]\] However, the impact of AKI on mortality in dengue is less well-studied. We found a significantly increased rate of mortality (15.61%) in patients with AKI, and interestingly no mortality in patients without AKI. Therefore, the presence of AKI in DVI predicts increased morbidity and mortality. The financial burden associated with DVI-associated AKI is of particular importance in a resource-limited setting such as ours.

Kaplan--Meier survival analysis based on total hospitalization days from the day of admission to discharge, among patients with DF or DHF/DSS in the renal impairment group and in non-renal impairment group \[[Figure 1](#F1){ref-type="fig"}\], showed that patients with DHF/DSS in the renal impairment group had significantly higher mortality when compared with other groups by log-rank test (*p* \< 0.001). Kuo *et al*.\[[@ref32]\] have also shown that patients with DHF/DSS in the AKI group had significantly higher mortality than those without AKI. No specific preventive strategies are available for AKI apart from adequate fluid resuscitation, management of dengue-associated coagulopathies, and avoidance of nephrotoxic agents. Inotropic support is of benefit. Dialysis is certainly beneficial, although the exact role of dialysis remains controversial.\[[@ref4]\]

Limitations of study {#sec2-2}
--------------------

This study had following limitations.

The study is retrospective and a single-center study focused on inpatients, which could have influenced the severity of dengue infection encountered and the incidence of AKI observedHistopathology reports were not available of patients with AKILong-term follow-up after discharge is not available.

Conclusion {#sec1-5}
==========

AKI in dengue infection, is usually associated with significant morbidity and mortality. Patients with DVI who develop AKI should be vigilantly monitored preferably in a special care unit. The presence of AKI should alert clinicians to the need for admission and early initiation of supportive treatment under close monitoring to avoid morbidity and mortality associated with this complication.
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